Scientific Program

Filter Results:

Show Only CME Accredited Sessions

  • +

    IS02 - Symposium by Ology Medical Education: Spotlight On Emerging Immunotherapy Approaches And MET Inhibitors In Advanced NSCLC (Not IASLC CME Accredited)

    • Type: Industry Symposia & Workshops
    • Track:
  • +

    IS03 - Symposium by Takeda Oncology: Current Treatment Landscape And Unmet Needs In ALK+ NSCLC (Not IASLC CME Accredited)

    • Type: Industry Symposia & Workshops
    • Track:
  • +

    IS04 - Symposium by Bristol-Myers Squibb: Point/Counterpoint: Maximizing the Impact of I-O Across NSCLC (Not IASLC CME Accredited)

    • Type: Industry Symposia & Workshops
    • Track:
  • +

    IS05 - Symposium by Springer Healthcare: Simplifying The Sequencing Of Treatment In NSCLC Patients With No Actionable Mutations (Not IASLC CME Accredited)

    • Type: Industry Symposia & Workshops
    • Track:
  • +

    PR01 - Press Conference

    • Type: Press Conference
    • Track:
    • +

      PR01.01 - Welcome from the IASLC CEO

      16:00 - 16:08

      • Abstract

      Abstract not provided

    • +

      PR01.02 - Welcome from Co-Chairs

      16:08 - 16:20

      • Abstract

      Abstract not provided

    • +

      PR01.03 - 20th WCLC Highlights

      16:20 - 16:32

      • Abstract

      Abstract not provided

    • +

      PR01.04 - STARS Program Announcement

      16:32 - 16:44

      • Abstract

      Abstract not provided

    • +

      PR01.05 - IASLC Molecular Testing Survey

      16:44 - 16:56

      • Abstract

      Abstract not provided

    • +

      PR01.06 - IASLC Tobacco Declaration

      16:56 - 17:08

      • Abstract

      Abstract not provided

    • +

      PR01.07 - Lung Ambition Alliance

      17:08 - 17:20

      • Abstract

      Abstract not provided

  • +

    S02 - Symposium Honoring Dr. Gazdar's Legacy (Sign Up Required)

    • Type: Symposium
    • Track: Pathology
    • +

      S02.01 - Introduction

      17:30 - 17:35  |  Presenting Author(s): Ignacio Wistuba

      • Abstract

      Loading...

    • +

      S02.02 - Adi Gazdar’s Legacy

      17:35 - 17:45  |  Presenting Author(s): Peter Ujhazy  |  Author(s): Melissa Antman, Christine Burgess, James L Mulshine

      • Abstract

      Loading...

    • +

      S02.03 - The Impact of Cell Line Development in Lung Cancer Research

      17:45 - 18:00  |  Presenting Author(s): Paul A Bunn, Jr

      • Abstract

      Loading...

    • +

      S02.04 - Dr. Gazdar as a Mentor

      18:00 - 18:15  |  Presenting Author(s): Tetsuya Mitsudomi

      • Abstract

      Loading...

    • +

      S02.05 - The Importance of Elucidating Genomic Events is Lung Premalignancy

      18:15 - 18:30  |  Presenting Author(s): Kwun M Fong

      • Abstract

      Loading...

    • +

      S02.06 - New Developments in SCLC and Neuroendocrine Tumors

      18:30 - 18:45  |  Presenting Author(s): Lauren Averett Byers

      • Abstract

      Loading...

    • +

      S02.07 - Dr. Gazdar as a Friend and Final Remarks

      18:45 - 19:00  |  Presenting Author(s): Fred R. Hirsch

      • Abstract

      Abstract not provided

  • +

    IASLC Award Session

    • Type: Travel Award Session
    • Track:
    • +

      IASLC Award Session

      17:45 - 18:45

      • Abstract

      Abstract not provided

  • +

    OC01 - Opening Ceremony

    • Type: Opening Ceremony
    • Track:
  • +

    Networking Welcome Reception

    • Type: Social Functions
    • Track:
    • +

      Networking Welcome Reception

      20:30 - 22:00

      • Abstract

      Abstract not provided

  • +

    IBS01 - My Oligometastatic Oncogene Driven Patient (Ticketed Session)

    • Type: Interactive Breakfast Session
    • Track: Targeted Therapy
    • +

      IBS01.01 - Systemic or Local Treatment: What to Do First?

      07:00 - 07:20  |  Presenting Author(s): Benjamin J Solomon

      • Abstract

      Loading...

    • +

      IBS01.02 - Strategies Treatment After Oligoprogression

      07:20 - 07:40  |  Presenting Author(s): Federico Cappuzzo  |  Author(s): Lorenza Landi

      • Abstract

      Loading...

    • +

      IBS01.03 - Q&A

      07:40 - 08:00

      • Abstract

      Abstract not provided